Literature DB >> 26032843

Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention for Veterans.

Barry L Carter1,2,3, Mark W Vander Weg2,4,5, Christopher P Parker1, Cassie C Goedken2, Kelly K Richardson2, Gary E Rosenthal2,4,6.   

Abstract

Clinical pharmacists are utilized in Veterans Health Administration (VHA) facilities to assist with management of patients with chronic conditions including hypertension. The goal of this study was to examine blood pressure (BP) control after discontinuation of an intensive pharmacist-managed intervention. The study was conducted at a single Midwest VHA medical center and two affiliated community-based outpatient clinics. Patients with uncontrolled BP received an intensive pharmacist intervention for the first 6 months. Patients were then stratified based on whether their BP was controlled or not and were randomized to either continue the intervention for another 24 months (30 month total time period) or the intervention was discontinued following one-time receipt of educational materials. Mean systolic and diastolic BPs were reduced (P<.001) in diabetic patients (8.0±14.4 mm Hg and 4.0±9.1 mm Hg, respectively) and in nondiabetic patients (14.0±16.4 mm Hg and 5.0±10.0 mm Hg, respectively) following the 6-month intervention, with 54% of the total sample achieving BP control. BP control and the reduction in mean BP was maintained to a similar degree in both study groups at 12, 18, 24, and 30 months. There were no significant differences in BP at any of the follow-up periods in patients who did and did not receive the continued pharmacist intervention. This study found that BP control was maintained for at least 24 months following discontinuation of an intensive pharmacist intervention. These findings were seen in both the group that had a continued pharmacist intervention and in the group that had a one-time educational session when the intervention was discontinued. This study suggests that once BP control is achieved following a pharmacist intervention, patients can be referred back to their primary care provider for continued follow-up. ©2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26032843      PMCID: PMC8032120          DOI: 10.1111/jch.12577

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  29 in total

1.  Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol.

Authors:  T K Makris; G A Stavroulakis; P G Krespi; A N Hatzizacharias; F K Triposkiadis; C G Tsoukala; V V Votteas; M K Kyriakidis
Journal:  Am J Hypertens       Date:  2000-07       Impact factor: 2.689

2.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

3.  Sustained blood pressure control following discontinuation of a pharmacist intervention.

Authors:  Danielle M Wentzlaff; Barry L Carter; Gail Ardery; Carrie L Franciscus; William R Doucette; Elizabeth A Chrischilles; Kurt A Rosenkrans; Lucinda M Buys
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-03-18       Impact factor: 3.738

4.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

5.  Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.

Authors:  Barry L Carter; William R Doucette; Carrie L Franciscus; Gail Ardery; Karen M Kluesner; Elizabeth A Chrischilles
Journal:  Pharmacotherapy       Date:  2010-03       Impact factor: 4.705

6.  Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the Veterans Administration health data repository.

Authors:  Ross D Fletcher; Richard L Amdur; Robert Kolodner; Chris McManus; Ronald Jones; Charles Faselis; Peter Kokkinos; Steven Singh; Vasilios Papademetriou
Journal:  Circulation       Date:  2012-04-19       Impact factor: 29.690

7.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

8.  Improving blood pressure control in a pharmacist-managed hypertension clinic.

Authors:  Eva M Vivian
Journal:  Pharmacotherapy       Date:  2002-12       Impact factor: 4.705

9.  Role of the clinical pharmacist in improving drug therapy. Clinical pharmacists in outpatient therapy.

Authors:  R Monson; C A Bond; A Schuna
Journal:  Arch Intern Med       Date:  1981-10

10.  A mixed-method approach to evaluate a pharmacist intervention for veterans with hypertension.

Authors:  Christopher P Parker; Cassie L Cunningham; Barry L Carter; Mark W Vander Weg; Kelly K Richardson; Gary E Rosenthal
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02       Impact factor: 3.738

View more
  3 in total

Review 1.  Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.

Authors:  Greg Weeks; Johnson George; Katie Maclure; Derek Stewart
Journal:  Cochrane Database Syst Rev       Date:  2016-11-22

2.  Sustained Blood Pressure Control Following Discontinuation of a Pharmacist Intervention for Veterans.

Authors:  Barry L Carter; Mark W Vander Weg; Christopher P Parker; Cassie C Goedken; Kelly K Richardson; Gary E Rosenthal
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-01       Impact factor: 3.738

3.  Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.

Authors:  Karen L Margolis; Stephen E Asche; Steven P Dehmer; Anna R Bergdall; Beverly B Green; JoAnn M Sperl-Hillen; Rachel A Nyboer; Pamala A Pawloski; Michael V Maciosek; Nicole K Trower; Patrick J O'Connor
Journal:  JAMA Netw Open       Date:  2018-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.